PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY

by B. A. Tatarskii
Published 2015-12-01

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhyth...

by Amine El Amrani, Xavier Viñolas, Miguel Angel Arias, Victor Bazan, Pilar Valdovinos, Josep M. Alegret
Published 2021-03-01

Unusual severe hemodynamic failure associated with standard dose of intravenous flecainide for pharmacological cardioversion of atrial fibrillation

by Aref Albakri, MD, Thomas Klingenheben, MD, FESC
Published 2017-09-01

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial

by I. G. Fomina, A. V. Vetlyzhsky, A. I. Tarzimanova, A. A. Abramova
Published 2005-04-01

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the A...

by Farkowski Michal M, Maciag Aleksander, Dabrowski Rafal, Pytkowski Mariusz, Kowalik Ilona, Szwed Hanna
Published 2012-09-01

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness

by N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Published 2018-11-01

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety

by N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Published 2019-01-01

Strategy and tactics of emergency treatment of atrial fibrillation: a modern approach to the problem

by Yu. A Bunin
Published 2015-03-01

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account

by Fabiana Lucà, Simona Giubilato, Stefania Angela Di Fusco, Laura Piccioni, Carmelo Massimiliano Rao, Annamaria Iorio, Laura Cipolletta, Emilia D’Elia, Sandro Gelsomino, Roberta Rossini, Furio Colivicchi, Michele Massimo Gulizia
Published 2021-07-01

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

by E B Maĭkov, Iu A Iuricheva, N Iu Mironov, S F Sokolov, S P Golitsyn, L V Rozenshtraukh, E I Chazov
Published 2015-01-01

Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment

by Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova
Published 2018-09-01